Aestimatio de HPV Genotyping sicut Diagnostic biomarkers de ceruicis cancer periculo - De applications de HPV genotyping deprehensio

HPV infectio est crebris in fornicatur activae populus, sed pertinax infectio evolvat solum in parva proportio casibus. HPV perseverare involves periculum developing precienrous cervix laesiones et tandem, ceruicis cancer

HPVs non excultusIn vitroPer conventional modi, et late naturalis variation of the animal immune responsio post infectio impairs usum HPV-specifica Antibdy testing in diagnosi. HPV infectio est ergo effectum per Molecular testis, maxime deprehendatur genomic HPV DNA.

Currently, a wide varietate commercial HPV genotyping modi est. Electio autem magis convenientem unum pendent in animo usu, id est: Epidemiology, Vaccine iudicium, aut orci studiis.

Nam Epidemiological Studies, HPV Genotyping modi patitur drawing of type specifica invaluisset.
Nam Vaccinum iudicium, haec assays praebere notitia in Circa mutationes inuenit in HPV genera non includitur in current Vaccines, et facilitate sequi de perseverare infectiones
Nam orci studiis, in current guidelines suadeo usum HPV gnotyping probat inter mulieres XXX annos et senior cum negative Cytologia et HR HPV positivum eventus, in speciali HP, XVI et HPV, XVIII. Detecting HPV et discriminating high- et humilis-periculo genotypes bis vel magis invenire aegris cum eodem genotype pertinax infectiones, unde in melius orci procuratio.

Macro & micro-test HPV Gnotyping Kits:

Key Product Features:

  • Simultaneous deprehendatur multiple genotypes in una reactionem;
  • Short PCR Turnaround tempus enim velox orci decisiones;
  • Magis sample genera (urina / swab) pro magis comfortable et accessible HPV infectio protegendo;
  • Dual internum controllata prohibet falsum positiva et sanat test reliability;
  • Liquid et lyophilized versions ad clients, optiones;
  • Compatibility cum maxime PCR systems ad magis Lab adaptability.

 

Internationalis dies actiones pro Women scriptor Health_ 画板 I 副本 画板 I 副本

Post tempus: Jun-04-2024